Literature DB >> 3340104

Liver disease and common-bile-duct stenosis in cystic fibrosis.

K J Gaskin1, D L Waters, R Howman-Giles, M de Silva, J W Earl, H C Martin, A E Kan, J M Brown, S F Dorney.   

Abstract

To determine the incidence of common-bile-duct lesions and their relation to liver disease in cystic fibrosis, we performed hepatobiliary scanning in 50 of 61 patients with cystic fibrosis who had hepatomegaly, abnormal liver function, or both and in 31 of 92 patients with cystic fibrosis who did not have hepatomegaly or abnormal liver function. Ninety-six percent of the patients with liver disease had evidence of biliary tract obstruction, which was defined cholangiographically as a stricture of the distal common bile duct in the majority of cases. All the patients without liver disease had normal intrahepatic and common-duct excretion of tracer. Abdominal pain was significantly more common in patients with common-duct obstruction (P less than 0.001), and enlarged gallbladders occurred only in such patients. Since fasting levels of serum bile acids were elevated in nearly half these patients, irrespective of the severity of their liver disease, serum bile acids may be markers of the severity of the common-duct lesion. We conclude that strictures of the distal common bile duct are common in patients with cystic fibrosis and liver disease. This association requires further study, since surgical relief of common-duct obstruction may prevent or ameliorate the hepatic complications of cystic fibrosis.

Entities:  

Mesh:

Year:  1988        PMID: 3340104     DOI: 10.1056/NEJM198802113180602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  30 in total

Review 1.  Cystic fibrosis, pathophysiological and clinical aspects.

Authors:  H J Neijens; M Sinaasappel; R de Groot; J C de Jongste; S E Overbeek
Journal:  Eur J Pediatr       Date:  1990-08       Impact factor: 3.183

2.  Prevalence of liver disease in cystic fibrosis.

Authors:  R Scott-Jupp; M Lama; M S Tanner
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

Review 3.  Cystic fibrosis. 6. Gastrointestinal and nutritional aspects.

Authors:  H Kopelman
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

4.  Liver and biliary problems in cystic fibrosis.

Authors:  M S Tanner
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

Review 5.  Patterns of GI disease in adulthood associated with mutations in the CFTR gene.

Authors:  Michael Wilschanski; Peter R Durie
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

Review 6.  Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Thomas Kelly; James Buxbaum
Journal:  Dig Dis Sci       Date:  2015-02-04       Impact factor: 3.199

7.  Peripheral nerve dysfunction in adult patients with cystic fibrosis.

Authors:  J I O'Riordan; J Hayes; M X Fitzgerald; J Redmond
Journal:  Ir J Med Sci       Date:  1995 Jul-Sep       Impact factor: 1.568

8.  A prognostic model for the prediction of survival in cystic fibrosis.

Authors:  K M Hayllar; S G Williams; A E Wise; S Pouria; M Lombard; M E Hodson; D Westaby
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

9.  Multidisciplinary Treatment of Cystic Fibrosis-Related Recurrent Pyogenic Cholangitis (CF-RPC).

Authors:  James Buxbaum; Nancy Nguyen; Sujit Kulkarni; Suzanne Palmer; Adupa Rao; Robert Selby
Journal:  Dig Dis Sci       Date:  2015-01-29       Impact factor: 3.199

10.  Cftr controls lumen expansion and function of Kupffer's vesicle in zebrafish.

Authors:  Adam Navis; Lindsay Marjoram; Michel Bagnat
Journal:  Development       Date:  2013-03-13       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.